Divalproex Sodium Tablet, Delayed Release
Product Images NDC 70518-3055

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-3055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Divalproex Sodium 250mg 70518 3055 01

Divalproex Sodium 250mg 70518 3055 01
Divalproex Sodium is a medication that comes in a tablet form and has a strength of 250 mg. The medication is manufactured by Rising Pharma, Inc. located in Allendale, NJ 0740. The National Drug Code (NDC) for this medication is 70518-3055-01. The medication is in a delayed-release form, and the source NDC is 57237-0047-01. The medication should be kept out of reach of children, and the instructions for use can be found in the package insert. It is recommended to store the medication at a temperature between 20-26°C (63-77°F), and excursions are permitted at 15-30°C (59-86°F) [as per regulations defined in USP]. However, the text seems to have some non-ASCII characters and appears to be a bit distorted.*
FDA Label Image

Divalproex Sodium 250mg 70518 3055 02

Divalproex Sodium 250mg 70518 3055 02
Divalproex Sodium Delayed-Release is a medication that is produced by Rising Pharma, Inc., based in Allendale, NJ 07401. The medication is stored at a temperature of 20-26°C (63-77°F), with excursions permitted up to 15-30°C (59-86°F) as per USP regulations. It is repackaged by RemedyRepack Inc., based in Indiana, PA 15701, and the package insert should be consulted for the directions for use. The medication should be kept out of reach of children. The expiration date and lot number are not available in the text.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a medication called Divalproex Sodium with dosage strength of 250mg. The NDC number for this medication is 70518-3055-00 and it is manufactured by Rising Pharma Inc, Allendale, NJ. The lot number and expiry details are missing. The medication should be kept out of reach of children and should be stored at a temperature of 20-26°C (63-77°F) with excursions allowed to 15-30°C (59-86°F). The package insert should be consulted for directions on use.*
FDA Label Image

Figure 1 (Divalproex Fig1)

Figure 1 (Divalproex Fig1)
FDA Label Image

Figure 2 (Divalproex Fig2)

Figure 2 (Divalproex Fig2)
FDA Label Image

Figure 3 (Divalproex Fig3)

Figure 3 (Divalproex Fig3)
This appears to be a graph displaying the reduction in CPS (unknown terminology) rate for high dose and low dose groups. The x-axis shows a percentage of patients while the y-axis shows percentage improvement, no change, and worsening. There is no further context provided.*
FDA Label Image

Figure 4 (Divalproex Fig4)

Figure 4 (Divalproex Fig4)
This is a figure showing the mean 4-week migraine rates for two studies (Study 1 and Study 2) comparing a placebo to a medication called divalproex sodium in delayed-release tablets. The mean dose of divalproex sodium delayed-release tablets in Study 1 was 1,087 mg/day, while in Study 2 the dose was either 500 or 1,000 mg/day.*
FDA Label Image

Chemical Structure (Divalproex Str)

Chemical Structure (Divalproex Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.